AGILE THERAPEUTICS INC (AGRX)
Institutional ownership reported to the SEC as of Q1 2024, across 18 quarters.
1
Reporting holders
$596
Reported value
0.0%
Held as options
-17
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| INVESTOR AB | $596 | 1,754 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 1 | $596 | 1,754 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 18 | $396.3K | 203,027 | 4 | 7 | 2 | 0.0% |
| Q3 2023 | 16 | $355.2K | 147,682 | 4 | 2 | 4 | 0.0% |
| Q2 2023 | 15 | $425.8K | 144,428 | 15 | 0 | 0 | 0.0% |
| Q1 2022 | 2 | $4.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2021 | 2 | $34.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2021 | 2 | $90.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2021 | 2 | $105.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2021 | 2 | $705.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2020 | 2 | $305.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2020 | 2 | $343.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2020 | 2 | $382.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2020 | 2 | $169.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2019 | 2 | $183.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q3 2019 | 2 | $61.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2019 | 2 | $91.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2019 | 2 | $88.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2018 | 2 | $6.0K | 0 | 0 | 0 | 0 | 100.0% |